| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
ABO-A2 red cell agglutination titres: Not the solution to improved ABO-A2-incompatible transplant eligibility assessment
|
Halpin, A.M.
|
|
|
85 |
S |
p.
|
artikel
|
| 2 |
Absence of the GSTT1 gene in a recipient can cause anti-GSTT1 non-HLA antibody development contributing to AMR
|
Nunugonda, M.
|
|
|
85 |
S |
p.
|
artikel
|
| 3 |
Absolute quantification of dd-cfDNA using a novel NGS assay
|
Pettersson, L.
|
|
|
85 |
S |
p.
|
artikel
|
| 4 |
A buccal swab DNA extraction method for Next Generation Sequencing
|
Britton, R.M.
|
|
|
85 |
S |
p.
|
artikel
|
| 5 |
A case of unexpected positive T cell flow crossmatch: Ibalizumab interference and how to avoid it
|
Zhang, W.
|
|
|
85 |
S |
p.
|
artikel
|
| 6 |
A common laboratory challenge: Harmonizing the HLA DPB1 antibody specificity nomenclature, and UNOS requirements, for unacceptable antigens in HistoTrac using software automation
|
Fisher, P.R.
|
|
|
85 |
S |
p.
|
artikel
|
| 7 |
Acute heart transplant rejection in the presence of weak DSA with negative flow cytometry crossmatch
|
Ji, R.
|
|
|
85 |
S |
p.
|
artikel
|
| 8 |
Addressing the hurdles in detecting alpha/beta-specific antibodies and the impact of limited bead coverage on accurate interpretation of the immunizing epitope
|
MarElia-Bennett, C.
|
|
|
85 |
S |
p.
|
artikel
|
| 9 |
Advancements in monitoring donor-derived cell-free DNA for improved kidney retransplantation outcomes
|
Westerling, S.
|
|
|
85 |
S |
p.
|
artikel
|
| 10 |
Advancing transplantation monitoring and disease insight: A Next-Generation Sequencing Assay for detecting HLA loss
|
Pettersson, L.
|
|
|
85 |
S |
p.
|
artikel
|
| 11 |
A method for identifying genomic regions with high risk of consensus base call error in Next Generation Sequencing
|
Avelar-Barragan, J.
|
|
|
85 |
S |
p.
|
artikel
|
| 12 |
Analysis of non-consensus antibodies observed in the ASHI-PT survey
|
Achram, R.
|
|
|
85 |
S |
p.
|
artikel
|
| 13 |
An extended machine learning approach for binning donor-recipient HLA amino acid mismatches to predict kidney graft failure risk
|
Urbanowicz, R.J.
|
|
|
85 |
S |
p.
|
artikel
|
| 14 |
An HLA genotype-informed dPCR assay for monitoring donor-derived cfDNA
|
Luiken, B.
|
|
|
85 |
S |
p.
|
artikel
|
| 15 |
A novel assay to accurately measure TorqueTenovirus load for immunosuppression level monitoring in transplant recipients
|
Alhadid, Y.
|
|
|
85 |
S |
p.
|
artikel
|
| 16 |
A novel genotyping test for tacrolimus dose optimization
|
Chadha, A.
|
|
|
85 |
S |
p.
|
artikel
|
| 17 |
A novel HLA loss assay revealing partial HLA loss
|
Geerligs, J.
|
|
|
85 |
S |
p.
|
artikel
|
| 18 |
Anti-Vedolizumab abrogates false positive allogeneic T and B cell flow cytometry crossmatches in solid organ transplantation
|
Altunkaynak, C.
|
|
|
85 |
S |
p.
|
artikel
|
| 19 |
Apparent maternal exclusion explained by a MICA deletion
|
Skaljic, I.
|
|
|
85 |
S |
p.
|
artikel
|
| 20 |
Are DQ8 and DQ9 an acceptable mismatch in transplantation?
|
Douglas, K.
|
|
|
85 |
S |
p.
|
artikel
|
| 21 |
Assessing DQB1 immunogenicity using the two mismatches one DSA approach in a local kidney transplant cohort
|
Chou-Wu, E.
|
|
|
85 |
S |
p.
|
artikel
|
| 22 |
Assessing impacts of transfusions on HLA sensitization in pre-hematopoietic stem cell transplant patients
|
Wali, J.
|
|
|
85 |
S |
p.
|
artikel
|
| 23 |
Assessing the clinical utility of the ExPlex Panel in a cohort of highly sensitized Black Americans
|
Morris, A.B.
|
|
|
85 |
S |
p.
|
artikel
|
| 24 |
Assessing trends in HLA-DQ genotype prevalence for celiac disease
|
Dionne, S.
|
|
|
85 |
S |
p.
|
artikel
|
| 25 |
Assessment of automated cell-free DNA extraction utilizing Promega Maxwell
|
Willis, A.
|
|
|
85 |
S |
p.
|
artikel
|
| 26 |
Assessment of buccal swab performance utilizing hybrid capture technology
|
Morris, T.
|
|
|
85 |
S |
p.
|
artikel
|
| 27 |
Assessment of the effect of UNOS new CPRA calculator implemented in January 2023 on rate of transplant for sensitized and non-sensitized deceased kidney and pancreas transplants for patient population at Cedars Sinai Medical Center
|
Naim, M.R.
|
|
|
85 |
S |
p.
|
artikel
|
| 28 |
A T-cell positive, B-cell negative allo flow crossmatch with a double-negative auto flow crossmatch: Interference of therapeutic brodalumab in a kidney transplant patient with psoriasis
|
Reiling, S.J.
|
|
|
85 |
S |
p.
|
artikel
|
| 29 |
Author Index
|
|
|
|
85 |
S |
p.
|
artikel
|
| 30 |
Automation of multiplexed 11-Loci HLA NGS Illumina library preparation on the HLA PRO Instrument
|
McFaul, M.
|
|
|
85 |
S |
p.
|
artikel
|
| 31 |
Breaking Bw4 barriers in highly sensitized lung transplant patients
|
Shinn, D.J.
|
|
|
85 |
S |
p.
|
artikel
|
| 32 |
Can median fluorescence intensity of HLA antibody detected by LABScreen Single Antigen Bead assay absolutely predict C1q activity?
|
Zhang, A.
|
|
|
85 |
S |
p.
|
artikel
|
| 33 |
Characterization of a De Novo recipient-specific anti-HLA antibody following a second haploidentical transplant
|
Lima, A.C.
|
|
|
85 |
S |
p.
|
artikel
|
| 34 |
Characterization of HIV epitopes restricted by the Amerindian B*39:02 subtype using synthetic peptides that encompass described HLA-associated polymorphisms
|
Soto-Nava, M.
|
|
|
85 |
S |
p.
|
artikel
|
| 35 |
Characterizing MHC ancestral haplotypes from genotyping MHC loci in parent-child trio’s of the Thousand Genome Project
|
Wang, T.
|
|
|
85 |
S |
p.
|
artikel
|
| 36 |
Chimerism testing for postmortem evaluation of solid organ and transfusion associated graft-vs-host disease
|
Franz, B.J.
|
|
|
85 |
S |
p.
|
artikel
|
| 37 |
Clinical utility of autologous flow cytometric crossmatches in transplant patients: A single center study
|
Muluhngwi, P.
|
|
|
85 |
S |
p.
|
artikel
|
| 38 |
Combined NGS sequencing for HLA typing and chimerism
|
Tyler, J.
|
|
|
85 |
S |
p.
|
artikel
|
| 39 |
Comparative analysis of PAK LX and SAG in HLA class I antibody screening: Implications for transfusion medicine
|
Gaule, L.
|
|
|
85 |
S |
p.
|
artikel
|
| 40 |
Comparative analysis of serum pretreatment strategies to remove non-specific serum interference in HLA antibody assessment
|
Jain, D.
|
|
|
85 |
S |
p.
|
artikel
|
| 41 |
Comparing the performance of Devysers and CareDx NGS-based assays for monitoring donor-derived cell-free DNA in kidney allografted patients
|
Plesner, A.
|
|
|
85 |
S |
p.
|
artikel
|
| 42 |
Comparison between two commercially available Luminex non-HLA antibody assays
|
Gimferrer, I.
|
|
|
85 |
S |
p.
|
artikel
|
| 43 |
Comparison of alloimmune risk stratification method for kidney transplants: Correlation with outcomes from a single center pediatric transplant program
|
Li, Y.
|
|
|
85 |
S |
p.
|
artikel
|
| 44 |
Comparison of two Elisa-based Angiotensin II-type-1 receptor (AT1R) autoantibody detection assays using an antibody cross-reactivity check approach
|
Karamafrooz, A.N.
|
|
|
85 |
S |
p.
|
artikel
|
| 45 |
Complement fixing HLA-C antibodies in a pre-transplant lung patient sensitized by pregnancy: To cross or not to cross?
|
Lee, M.
|
|
|
85 |
S |
p.
|
artikel
|
| 46 |
Concentration-dependent antibody specificity profiles of human leukocyte DQ antigens and predictions of functional epitopes
|
Meng, S.
|
|
|
85 |
S |
p.
|
artikel
|
| 47 |
Confounding variables such as previous transplants, gender, ethnicity, and primary disease complicate the diagnostic validity of single-antigen bead-based non-HLA antibody assays
|
Raja, R.
|
|
|
85 |
S |
p.
|
artikel
|
| 48 |
Correlation between real time PCR and NGS on deceased donor typing and its impact on the virtual crossmatch
|
Grewal, S.
|
|
|
85 |
S |
p.
|
artikel
|
| 49 |
COVID-19 vaccine side effects are associated with HLA-A*03:01 carriage and fewer breakthrough infections
|
Srivastava, A.
|
|
|
85 |
S |
p.
|
artikel
|
| 50 |
Defining functional epitopes of human leukocyte DQ antigens using a new single antigen bead panel and engineered variants
|
Meng, S.
|
|
|
85 |
S |
p.
|
artikel
|
| 51 |
De novo production of granulocyte-macrophage colony-stimulating factor antibodies following hematopoietic stem cell transplantation from HLA-matched unrelated donors is associated with acute graft-versus-host disease
|
Jakubauskas, A.
|
|
|
85 |
S |
p.
|
artikel
|
| 52 |
Desensitization of HLA antibodies in a pediatric heart transplant
|
Tapia, B.
|
|
|
85 |
S |
p.
|
artikel
|
| 53 |
Differential adsorption of HLA and non-HLA antibodies following combined liver and kidney transplantation
|
Lake, M.
|
|
|
85 |
S |
p.
|
artikel
|
| 54 |
Diversity and frequency of HLA-DRB1*15:03-DRB5* haplotypes in a large cohort: The case of the absent HLA-DRB5 revisited
|
Ponisciak, M.
|
|
|
85 |
S |
p.
|
artikel
|
| 55 |
Donor HLA-B-leader and HLA-DQ genotypes impact on outcomes following lung transplantation
|
Hiho, S.
|
|
|
85 |
S |
p.
|
artikel
|
| 56 |
Donor specific antibodies to DQ antigens are rare in DR antigen matched kidney transplants
|
Brown, N.K.
|
|
|
85 |
S |
p.
|
artikel
|
| 57 |
DR53 antibody positivity study: 50% or 0% cPRA
|
Kelley, B.
|
|
|
85 |
S |
p.
|
artikel
|
| 58 |
Early detection of acute graft versus host disease by assessment of the immunity related transcriptome
|
Kalra, A.
|
|
|
85 |
S |
p.
|
artikel
|
| 59 |
Efficient production of soluble class II HLA-Fc fusion proteins stabilized by interchain disulfide bond
|
Xiamuxiya, A.
|
|
|
85 |
S |
p.
|
artikel
|
| 60 |
Efficient resolution of non-specific binding patterns in a high-volume HLA lab
|
Portwood, E.
|
|
|
85 |
S |
p.
|
artikel
|
| 61 |
Endothelial derived extracellular vesicles express high level of HLA class II molecules under inflammatory conditions
|
Alkhaldi, E.H.
|
|
|
85 |
S |
p.
|
artikel
|
| 62 |
Enhanced mixed donor chimerism analysis with digital PCR
|
Yin, Y.
|
|
|
85 |
S |
p.
|
artikel
|
| 63 |
Enhancing reproducibility in immunogenetics: Leveraging containerization technology for bioinformatics workflows
|
Suseno, R.
|
|
|
85 |
S |
p.
|
artikel
|
| 64 |
Epitope mismatch load as potential driver of rejection in xenotransplantation
|
Chitnis, N.
|
|
|
85 |
S |
p.
|
artikel
|
| 65 |
Eplet mismatchs in predicting de novo donor-specific antibodies (dnDSA) in liver transplant patients
|
Ge, S.
|
|
|
85 |
S |
p.
|
artikel
|
| 66 |
Establishing the relationship between an adopted recipient and their HLA-matched related donor
|
Martin, R.
|
|
|
85 |
S |
p.
|
artikel
|
| 67 |
Establishment of T cell and B cell flow cytometric xenocrossmatching test
|
Cho, S.
|
|
|
85 |
S |
p.
|
artikel
|
| 68 |
Evaluating Daratumumab in the treatment of antibody mediated rejection in pediatric heart transplantation
|
Jindra, P.T.
|
|
|
85 |
S |
p.
|
artikel
|
| 69 |
Evaluating double-peak melt curves for the LinkSeqTM HLA-B*27 assay
|
Skibby, J.
|
|
|
85 |
S |
p.
|
artikel
|
| 70 |
Evaluating the shared epitope phenomenon using expanded single antigen bead panels
|
Pinelli, D.
|
|
|
85 |
S |
p.
|
artikel
|
| 71 |
Evaluation of cfDNA extraction method: for monitoring donor-derived cell-free DNA post-transplantation
|
Teefy, B.B.
|
|
|
85 |
S |
p.
|
artikel
|
| 72 |
Evaluation of spurious Luminex bead reactions with HISTO SPOT® HLA AB, flow cytometry cross matching and adsorption with crossmatch and elution
|
Emery, T.
|
|
|
85 |
S |
p.
|
artikel
|
| 73 |
Evaluation of the performance of next generation sequencing ABO probes in a solid organ transplant population
|
Gebhart, C.
|
|
|
85 |
S |
p.
|
artikel
|
| 74 |
Everything but the kitchen sink: Resolving an unusual DRB1*04:04 - DRB4*01:03N – DQB1*03:02 haplotype in a deceased donor
|
Christian, D.
|
|
|
85 |
S |
p.
|
artikel
|
| 75 |
Exploring bioinformatics tools for graft-versus-host disease risk prediction in hematopoietic cell transplantation: A study conducted at a Mexican center
|
Moncada-Saucedo, N.K.
|
|
|
85 |
S |
p.
|
artikel
|
| 76 |
Exploring the citrullination effects on the HLA-DRB1 structure and dynamics: Implications for the rheumatoid arthritis pathogenesis
|
Alves, C.C.
|
|
|
85 |
S |
p.
|
artikel
|
| 77 |
Extracting gDNA from clotted specimens: Validating the “crushed clot”
|
Carozza, C.
|
|
|
85 |
S |
p.
|
artikel
|
| 78 |
Feasibility of long fragment hybrid capture for long-read sequencing of HLA and beyond
|
Ventura, C.M.
|
|
|
85 |
S |
p.
|
artikel
|
| 79 |
Fifty-two novel HLA class I alleles identified during routine bone marrow donor registry typing
|
Hou, L.
|
|
|
85 |
S |
p.
|
artikel
|
| 80 |
Flowcytometry or Luminex crossmatch – Comparison and limitations
|
Mishra, M.N.
|
|
|
85 |
S |
p.
|
artikel
|
| 81 |
Front Matter
|
|
|
|
85 |
S |
p.
|
artikel
|
| 82 |
Functional epitope analysis of serum samples from transplant patients using LABScreen™, MagSort™, and cell-based adsorption elution reveals a deeper understanding of DQ antibody specificities
|
Suh, D.
|
|
|
85 |
S |
p.
|
artikel
|
| 83 |
Haplo-matched vs Haplo-identical
|
Martin, R.
|
|
|
85 |
S |
p.
|
artikel
|
| 84 |
Harnessing the power of immunoinformatics: Characterizing the role of T-cell immunity as an integral part of vaccine development and efficacy testing regimen
|
Kanga, U.
|
|
|
85 |
S |
p.
|
artikel
|
| 85 |
High-resolution MHC sequencing reveals local genetic architecture of multiple sclerosis in a trans-ethnic cohort
|
Wade, K.J.
|
|
|
85 |
S |
p.
|
artikel
|
| 86 |
High-throughput, high-resolution HLA typing using NGS-Pronto nanopore sequencing – a multicentre performance study
|
ter Steege, E.
|
|
|
85 |
S |
p.
|
artikel
|
| 87 |
HLA A10 spurious reactivity with single antigen beads investigated
|
Miller, M.
|
|
|
85 |
S |
p.
|
artikel
|
| 88 |
HLA-B*51:11N revealed by NGS in confirmatory deceased donor HLA typing
|
Shen, M.
|
|
|
85 |
S |
p.
|
artikel
|
| 89 |
HLA-C peptide repertoires as predictors of clinical response during early SARS-CoV-2 infection
|
Olp, M.
|
|
|
85 |
S |
p.
|
artikel
|
| 90 |
HLA detective work: DQA1*05:01 false positive?
|
Brailey, P.
|
|
|
85 |
S |
p.
|
artikel
|
| 91 |
HLA-DP antibodies targeting combined DPB1/DPA1 epitopes
|
Youngs, D.
|
|
|
85 |
S |
p.
|
artikel
|
| 92 |
HLA-DPB1 and DPA1∼DPB1 linkage mismatch affects the survival of recipients receiving HLA-14/14 matched unrelated donor HSCT
|
Zhang, T.
|
|
|
85 |
S |
p.
|
artikel
|
| 93 |
HLA-DPB1*23:01 is associated with severe cardiac conditions, sudden cardiac death and ventricular fibrillation, in Czech patients
|
Petrek, M.
|
|
|
85 |
S |
p.
|
artikel
|
| 94 |
HLA-DQ de novo donor-specific antibody development and its effect on renal allograft survival
|
Wong, E.
|
|
|
85 |
S |
p.
|
artikel
|
| 95 |
HLA-DQ heterodimer mismatch number is associated with de novo donor-specific antibody development in pediatric kidney transplant recipients
|
Sigurjonsdottir, V.K.
|
|
|
85 |
S |
p.
|
artikel
|
| 96 |
HLA-DRB1*03:05 at the antigen equivalency crossroads
|
Eltayeb Elsheikh, N.
|
|
|
85 |
S |
p.
|
artikel
|
| 97 |
HLA-DRB3/4/5 mismatches were unintentionally avoided in allogenic hematopoietic stem cell transplants
|
Smithers, E.
|
|
|
85 |
S |
p.
|
artikel
|
| 98 |
HLA-DR/DQ eplet mismatch predicts risk of de novo donor-specific antibody development in a multi-ethnic Southeast Asian cohort of kidney transplant recipients
|
Wong, E.
|
|
|
85 |
S |
p.
|
artikel
|
| 99 |
HLA-DR/DQ molecular mismatches for risk stratification and prediction of development of de novo donor-specific antibodies in cardiac allogeneic transplantation
|
Misra, M.K.
|
|
|
85 |
S |
p.
|
artikel
|
| 100 |
HLA PRO automation of 11 loci NGS assay library preparation for Ion Torrent
|
Ma, D.
|
|
|
85 |
S |
p.
|
artikel
|
| 101 |
HLA tailored immunosuppression in living related pediatric kidney transplants in a low-income country. Cost and survival benefits
|
Zafar, M.
|
|
|
85 |
S |
p.
|
artikel
|
| 102 |
HLA tissue typing and histocompatibility in supporting the Australian uterus transplant program
|
Thamotharampillai, K.
|
|
|
85 |
S |
p.
|
artikel
|
| 103 |
HLAtools for accelerating immunogenomic informatics
|
Tran, L.
|
|
|
85 |
S |
p.
|
artikel
|
| 104 |
HLA typing by Next Generation Sequencing (NGS): Validation using MGI DNBSEQ-G99
|
Silva, L.R.
|
|
|
85 |
S |
p.
|
artikel
|
| 105 |
How many clinical histocompatibility and immunogenetics laboratories are there in the world? A glance at their geographical distribution and accreditation
|
Bravo-Egana, V.
|
|
|
85 |
S |
p.
|
artikel
|
| 106 |
Human Leucocyte Antigen variation is associated with Cytomegalovirus serostatus
|
Boquett, J.A.
|
|
|
85 |
S |
p.
|
artikel
|
| 107 |
Identification of a near-miss sentinel event in a deceased donor kidney transplant candidate
|
Eltayeb Elsheikh, N.
|
|
|
85 |
S |
p.
|
artikel
|
| 108 |
Identification of a novel DQB1*03 allele in pseudo exon 5 by next generation sequencing HLA typing
|
Yeh, N.
|
|
|
85 |
S |
p.
|
artikel
|
| 109 |
Identification of DRB5*01:02 dropout in a long-range PCR-based next-generation sequencing HLA typing
|
Tang, X.
|
|
|
85 |
S |
p.
|
artikel
|
| 110 |
Identification of non-HLA autoantibodies associated with biopsy-proven rejection in kidney transplantation
|
Hu, Q.
|
|
|
85 |
S |
p.
|
artikel
|
| 111 |
Impact of CD36-directed antibodies in a case of stem cell transplantation
|
Lemieux, W.
|
|
|
85 |
S |
p.
|
artikel
|
| 112 |
Impact of non-human leukocyte antigen antibodies on delayed graft function, rejection, and graft survival in kidney transplantation
|
Sidahmed, A.
|
|
|
85 |
S |
p.
|
artikel
|
| 113 |
Impact of the virtual crossmatch assessment on transplant outcomes
|
Lewis, N.
|
|
|
85 |
S |
p.
|
artikel
|
| 114 |
Impact of Tocilizumab treatment on the reduction of angiotensin II type 1 receptor (AT1R) antibodies
|
Taniguchi, M.
|
|
|
85 |
S |
p.
|
artikel
|
| 115 |
Improvements of Omixon NanoTYPE HLA typing using Oxford Nanopore Technologies: Addressing the DQ3 drop-out issue
|
Tian, R.
|
|
|
85 |
S |
p.
|
artikel
|
| 116 |
Improving time management in chimerism testing: Implementing an automated patient worklist
|
Yurekci, E.
|
|
|
85 |
S |
p.
|
artikel
|
| 117 |
Imputing high-resolution genotypes from serological typing in a large clinical cohort
|
Ellison, M.A.
|
|
|
85 |
S |
p.
|
artikel
|
| 118 |
Integrating US census demographic data with HLA frequencies to accelerate targeted cell therapy patient enrollment
|
Roy, C.K.
|
|
|
85 |
S |
p.
|
artikel
|
| 119 |
Interference for CD3+ and CD19+ subset enrichment by immunomagnetic beads
|
Kim, E.
|
|
|
85 |
S |
p.
|
artikel
|
| 120 |
Inter-laboratory flow cytometric crossmatch variability: Lessons learned from proficiency testing
|
Philogene, M.
|
|
|
85 |
S |
p.
|
artikel
|
| 121 |
Inverse correlation between MFI and bead counts in single antigen bead assay for anti-HLA antibody testing
|
Frick, R.
|
|
|
85 |
S |
p.
|
artikel
|
| 122 |
Investigating HLA-DRB1 genotypes as contributing risk factors for Staphylococcus aureus bacteremia
|
Kair, J.
|
|
|
85 |
S |
p.
|
artikel
|
| 123 |
Ischemia-reperfusion injury drives increased allosensitization to HLA-B, DQB1 and DPB1 and leads to poor outcomes in liver transplant recipients
|
Sosa, R.A.
|
|
|
85 |
S |
p.
|
artikel
|
| 124 |
Ischemia reperfusion injury drives post-operative monocyte differentiation and alloreactivity in orthotopic liver transplant patients
|
Bhat, A.
|
|
|
85 |
S |
p.
|
artikel
|
| 125 |
Isolating HLA-specific IgM and IgG from serum using different MagSort elution buffers
|
Abeywardana, T.
|
|
|
85 |
S |
p.
|
artikel
|
| 126 |
JoGo-LILR caller: Unveiling and navigating the diversity of LILRB3-LILRA6 copy number structures with whole-genome sequencing
|
Nagasaki, M.
|
|
|
85 |
S |
p.
|
artikel
|
| 127 |
Kinetic characterization of sera antibodies – A surface plasmon resonance study
|
Van Eps, N.
|
|
|
85 |
S |
p.
|
artikel
|
| 128 |
KIR2DL1*001/HLA-C2 is associated with risk for multiple sclerosis
|
Williams, J.C.
|
|
|
85 |
S |
p.
|
artikel
|
| 129 |
KIR3DL1*004 is associated with Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS)
|
Kizer, K.
|
|
|
85 |
S |
p.
|
artikel
|
| 130 |
LILR and LAIR gene capture for long read sequencing-based typing
|
Creutzburg, S.
|
|
|
85 |
S |
p.
|
artikel
|
| 131 |
LILR full gene variation in European and African American cohorts
|
Bhattacharya, A.
|
|
|
85 |
S |
p.
|
artikel
|
| 132 |
Long-distance phasing of short NGS reads – A novel approach to HLA haplotyping
|
Lind, C.
|
|
|
85 |
S |
p.
|
artikel
|
| 133 |
Loss of mismatched HLA during relapse in haplo stem cell transplant recipients with acute myelogenous leukemia
|
Wang, Q.
|
|
|
85 |
S |
p.
|
artikel
|
| 134 |
Management of a patient post-BMT and pre-heart transplant
|
Billand, K.
|
|
|
85 |
S |
p.
|
artikel
|
| 135 |
MICA and MICB allele frequencies in a Southwest US cohort
|
Bravo-Egana, V.
|
|
|
85 |
S |
p.
|
artikel
|
| 136 |
Misbhaving cells – Deceased donor with Crohn’s disease showed complete depletion of circulating B cells
|
Ruggio, N.
|
|
|
85 |
S |
p.
|
artikel
|
| 137 |
Multi-center evaluation of 19 loci hybrid capture NGS assay on illumina instruments
|
Nhan, J.
|
|
|
85 |
S |
p.
|
artikel
|
| 138 |
Multiplex long range PCR enrichment assay for HLA typing and ABO phenotyping
|
Ferguson, G.B.
|
|
|
85 |
S |
p.
|
artikel
|
| 139 |
Negative flow cytometric crossmatch in the presence of anti-A*74:01 DSA: A case study
|
Gvozdjan, K.
|
|
|
85 |
S |
p.
|
artikel
|
| 140 |
Negative virtual crossmatch (vXM) with positive flow cytometry crossmatch (FCXM) in absence of prozone and DSA can be due to HLA-C epitope-specific antibodies
|
Abu-Khader, A.
|
|
|
85 |
S |
p.
|
artikel
|
| 141 |
New method: For evaluating deviation from Hardy-Weinberg Equilibrium in large, real world HLA datasets
|
Shkuri, O.
|
|
|
85 |
S |
p.
|
artikel
|
| 142 |
Next generation sequencing for deceased donor HLA typing – The time is now
|
Murphey, C.
|
|
|
85 |
S |
p.
|
artikel
|
| 143 |
Next-level approach to AMR and TCMR diagnosis in kidney transplantation; the dynamic duo of urine CXCL10 and donor-derived cell free DNA
|
Fantus, D.
|
|
|
85 |
S |
p.
|
artikel
|
| 144 |
NGS typing analysis software fails to identify HLA-A*24:11N allele due to presence of homopolymer sequence
|
Spinelli, A.
|
|
|
85 |
S |
p.
|
artikel
|
| 145 |
Non-coding mismatches in HLA Class I genes in the presence of DPB1 mismatches predict worse outcomes in hematopoietic cell transplantation
|
Askar, M.
|
|
|
85 |
S |
p.
|
artikel
|
| 146 |
Non-inherited maternal HLA alleles detected in breast milk-contaminated buccal swabs
|
Miller, C.
|
|
|
85 |
S |
p.
|
artikel
|
| 147 |
Non-permissive HLA-DPB1 mismatches are associated with increased 1-year mortality after unrelated donor hematopoietic cell transplantation for non-malignant disorders
|
Getz, J.
|
|
|
85 |
S |
p.
|
artikel
|
| 148 |
Novel desensitization strategy in a highly sensitized heart/liver transplant candidate using imlifidase
|
Lazar-Molnar, E.
|
|
|
85 |
S |
p.
|
artikel
|
| 149 |
Novel null allele discovered by rapid next-gen sequencing
|
Femec, W.
|
|
|
85 |
S |
p.
|
artikel
|
| 150 |
Overcoming an obstacle-flow DSA XM for HIV+ transplant recipients
|
Langner, S.
|
|
|
85 |
S |
p.
|
artikel
|
| 151 |
Overcoming interference from anti-CD38 in flow cytometric crossmatch testing
|
Lucas, D.P.
|
|
|
85 |
S |
p.
|
artikel
|
| 152 |
Performance assessment of the One Lambda Devyser Accept cfDNA assay in lung transplantation
|
Daniels, L.
|
|
|
85 |
S |
p.
|
artikel
|
| 153 |
Persistence of HLA-specific DNA on MinION flow cells
|
Gautreaux, M.
|
|
|
85 |
S |
p.
|
artikel
|
| 154 |
Pooling HLA, chimerism, and cfDNA NGS libraries for sequencing on illumina instruments
|
Lopez, H.O.
|
|
|
85 |
S |
p.
|
artikel
|
| 155 |
Population study to define HLA in Mohawk First Nation in Quebec
|
Lemieux, W.
|
|
|
85 |
S |
p.
|
artikel
|
| 156 |
Population study to define HLA in Wendat First Nation in Quebec
|
Lemieux, W.
|
|
|
85 |
S |
p.
|
artikel
|
| 157 |
Positive flow crossmatches due to anti-ABO red blood cell antibodies
|
Rewinski, M.
|
|
|
85 |
S |
p.
|
artikel
|
| 158 |
Power BI for HLA
|
Taniguchi, M.
|
|
|
85 |
S |
p.
|
artikel
|
| 159 |
Precision in post-transplant management: Revealing epitope mismatch analysis for enhanced graft survival prediction
|
Wang, E.
|
|
|
85 |
S |
p.
|
artikel
|
| 160 |
PreSorb is superior to Adsorb Out in reducing high background and false positive reactivity in HLA single antigen bead assay
|
Xin, J.
|
|
|
85 |
S |
p.
|
artikel
|
| 161 |
Principal component analysis (PCA) identifies Bw4/Bw6 epitope and individual eplet patterns of reactivity in single antigen bead solid phase testing
|
Cornaby, C.
|
|
|
85 |
S |
p.
|
artikel
|
| 162 |
Profiling performance of high-resolution HLA imputation with complementary metrics and visualizations using an open-source validation framework
|
Paynter, A.N.
|
|
|
85 |
S |
p.
|
artikel
|
| 163 |
Protein losing enteropathy may pose a hidden danger to prospective heart transplant patients
|
Christakos, L.
|
|
|
85 |
S |
p.
|
artikel
|
| 164 |
Quantitative assessment of eplet mismatch impact on heart transplant outcomes: A comprehensive analysis across HLA loci
|
Sidahmed, A.
|
|
|
85 |
S |
p.
|
artikel
|
| 165 |
Rare DRB1*01 with DRB5 haplotype
|
Wagner, M.
|
|
|
85 |
S |
p.
|
artikel
|
| 166 |
Reconstitution of T cells at three months after stem cell transplant influences the discovery of predictive markers of relapse
|
Kalra, A.
|
|
|
85 |
S |
p.
|
artikel
|
| 167 |
Reducing new sample requests for high resolution HLA typing by next generation sequencing
|
Barone, J.
|
|
|
85 |
S |
p.
|
artikel
|
| 168 |
Reduction of HLA antibody in pediatric heart patients after daratumumab treatment for antibody mediated rejection
|
Najor, M.
|
|
|
85 |
S |
p.
|
artikel
|
| 169 |
Refining HLA-associated type 1 diabetes risk assessment with data from six understudied countries
|
Noble, J.A.
|
|
|
85 |
S |
p.
|
artikel
|
| 170 |
Relationship between HLA sensitization and heart transplant outcome
|
Lee, H.
|
|
|
85 |
S |
p.
|
artikel
|
| 171 |
Reporting HLA antigens for the DRB3/4/5 Locus at the first field in UNet would decrease rates of deceased donor offer refusal
|
Brown, N.K.
|
|
|
85 |
S |
p.
|
artikel
|
| 172 |
Resolving a relevant DPB1 Exon 3 polymorphism by HLA sequencing
|
Patel, L.R.
|
|
|
85 |
S |
p.
|
artikel
|
| 173 |
Risk of kidney graft failure (GF) associated with HLA class II amino acid mismatches (AAMM) is highest during the first year after transplant for sensitized patients
|
McCullough, K.
|
|
|
85 |
S |
p.
|
artikel
|
| 174 |
Role of epidermal growth factor in cardiac allograft injury
|
Moussa, O.
|
|
|
85 |
S |
p.
|
artikel
|
| 175 |
Sensitive and fast NGS-based chimerism monitoring using ONT sequencing
|
Rijkers, M.
|
|
|
85 |
S |
p.
|
artikel
|
| 176 |
Serological reactivity of HLA alleles is dependent on race/ethnicity
|
Yin, Y.
|
|
|
85 |
S |
p.
|
artikel
|
| 177 |
Short- and long-read next-generation sequencing approaches to characterize HLA-A*30 null alleles differing in the length of homopolymer C region of exon 4
|
Montero Martin, G.
|
|
|
85 |
S |
p.
|
artikel
|
| 178 |
Simplified technique sensitive washing steps for a robust hybrid capture target enrichment NGS assay
|
Martinez, M.E.
|
|
|
85 |
S |
p.
|
artikel
|
| 179 |
Single HLA-DQ2.2 haplotype, without HLA-DQ8 or DQ2.5 heterozygosity, demonstrates an association with Celiac disease
|
Sidahmed, A.
|
|
|
85 |
S |
p.
|
artikel
|
| 180 |
State income tax forms present an annual opportunity to grow the Organ Donor Registry
|
Sherrill, J.
|
|
|
85 |
S |
p.
|
artikel
|
| 181 |
Statistical modeling to assess variation between tests in single antigen bead analysis
|
Pickering, H.C.
|
|
|
85 |
S |
p.
|
artikel
|
| 182 |
Strategies for resolving and reporting uncommon null alleles in deceased donors for organ allocation
|
Cajulao, A.J.
|
|
|
85 |
S |
p.
|
artikel
|
| 183 |
Streamlining submission to the IPD-IMGT/HLA database: The sequence feature annotation tool
|
Barker, D.J.
|
|
|
85 |
S |
p.
|
artikel
|
| 184 |
Successful third transplant for recurrent leukemia after TLI-ATG conditioning and despite EBV-associated mixed donor chimerism
|
Suliman, A.
|
|
|
85 |
S |
p.
|
artikel
|
| 185 |
Successful transplantation across high titer pre-existing donor-specific antibodies (DSA) in addition to cases involving de novo DSA with no antibody-mediated rejection
|
Chemmalakuzhy, A.
|
|
|
85 |
S |
p.
|
artikel
|
| 186 |
Synergistic effect of DSA and non-HLA antibodies on T cell-mediated rejection of adult liver allografts
|
Xu, Q.
|
|
|
85 |
S |
p.
|
artikel
|
| 187 |
The complexity for transplanting HLA-B46 homozygous renal candidates
|
Pulido, M.A.
|
|
|
85 |
S |
p.
|
artikel
|
| 188 |
The differential impact of immunosuppressant withdrawal after graft failure on De Novo Class I and II antibody development
|
Zhu, H.
|
|
|
85 |
S |
p.
|
artikel
|
| 189 |
The DRB1*13:13 allele has a structure similar to that of the DRB1*08 group
|
Blair, L.C.
|
|
|
85 |
S |
p.
|
artikel
|
| 190 |
The impact of PIRCHE-II and ischemia reperfusion injury on dynamics of CD4+ T memory cells in liver transplant recipients
|
Hirata, M.
|
|
|
85 |
S |
p.
|
artikel
|
| 191 |
The presence of angiotensin type 1 receptor (AT1R) antibodies is associated with increased peripheral blood biomarkers and vasculopathy in cardiac transplant rejection
|
Yigitbilek, F.
|
|
|
85 |
S |
p.
|
artikel
|
| 192 |
The reduction in immunosuppression laboratory dilemma
|
Kummrow, M.
|
|
|
85 |
S |
p.
|
artikel
|
| 193 |
The risk of preexisting donor-specific IgG antibody with a negative flow crossmatch in kidney transplantation
|
Leising, M.
|
|
|
85 |
S |
p.
|
artikel
|
| 194 |
The role of anti-AT1R and HLA donor-specific antibodies in histologic and molecular assessment of cardiac allograft biopsies
|
Yigitbilek, F.
|
|
|
85 |
S |
p.
|
artikel
|
| 195 |
The success of liver transplantation in patients with pre-transplant positive crossmatch depends on the liver’s ability to clear donor specific antibodies: A case study
|
Sidahmed, A.
|
|
|
85 |
S |
p.
|
artikel
|
| 196 |
The transplantation of highly sensitized patients across DSA – What is acceptable and how do we decide?
|
Gareau, A.J.
|
|
|
85 |
S |
p.
|
artikel
|
| 197 |
The use of business intelligence software to promote quality and service excellence of laboratory operations
|
Marchioni, M.A.
|
|
|
85 |
S |
p.
|
artikel
|
| 198 |
Thymoglobulin therapy leads to false positive antibody and crossmatch results
|
Ji, R.
|
|
|
85 |
S |
p.
|
artikel
|
| 199 |
To list or not to list; A case of a highly sensitized kidney after liver transplant candidate
|
Hayde, N.
|
|
|
85 |
S |
p.
|
artikel
|
| 200 |
Transforming transplantation: Argentina’s voyage into the calculated panel reactive antibody era
|
Balekjian, B.
|
|
|
85 |
S |
p.
|
artikel
|
| 201 |
Transplant outcomes in lung transplant candidates desensitized with a daratumumab based protocol
|
Butler, C.L.
|
|
|
85 |
S |
p.
|
artikel
|
| 202 |
Treatment with bi-specific antibody blinatumomab effectively reduces HLA antibodies
|
Zhang, X.
|
|
|
85 |
S |
p.
|
artikel
|
| 203 |
Triple threat: Three typing assays resulted three different HLA-DPB1 typings
|
Crowther, G.
|
|
|
85 |
S |
p.
|
artikel
|
| 204 |
Troubleshooting apparent allelic dropout using two methods: of next generation sequencing
|
Netherton, E.
|
|
|
85 |
S |
p.
|
artikel
|
| 205 |
UCLA International MICA Exchange – An update
|
Locke, A.F.
|
|
|
85 |
S |
p.
|
artikel
|
| 206 |
Uncovering new potentials: High resolution deceased donor human leukocyte antigen typing in less than 4 hours
|
Johnson, S.
|
|
|
85 |
S |
p.
|
artikel
|
| 207 |
Uncovering the rarity: DR7-DR53-DQ9 haplotype in two Caucasian patients
|
Liu, J.
|
|
|
85 |
S |
p.
|
artikel
|
| 208 |
Undetected mixed chimerism in myeloid subset enrichments by an immunomagnetic bead-based method
|
McManus, P.
|
|
|
85 |
S |
p.
|
artikel
|
| 209 |
Use of intermediate-resolution deceased donor molecular typing in organ allocation systems could increase the fraction of HLA-compatible donor offers
|
Hossain, M.
|
|
|
85 |
S |
p.
|
artikel
|
| 210 |
Use of single antigen beads coated with engineered variants for mapping a functional epitope of an HLA-DQA1*01 specific antibody
|
Morris, A.B.
|
|
|
85 |
S |
p.
|
artikel
|
| 211 |
Use of titration for improving quantitative evaluation of Anti-HLA antibodies by SAB
|
Mehrabli, J.
|
|
|
85 |
S |
p.
|
artikel
|
| 212 |
Using MagSort to identify DSA eplets in a high PRA patient serum and reveal a unique novel HLA-A*01:01 reaction pattern
|
Vu, T.
|
|
|
85 |
S |
p.
|
artikel
|
| 213 |
Using PreSorb and MagSort to characterize pan-DR sera
|
Vu, T.
|
|
|
85 |
S |
p.
|
artikel
|
| 214 |
Validating residues determining epitopes and its possible application in clinical histocompatibility testing
|
Osoegawa, K.
|
|
|
85 |
S |
p.
|
artikel
|
| 215 |
Validation of Alloseq Tx11 – Next Generation Sequencing of 11 classical HLA loci
|
Morris, T.
|
|
|
85 |
S |
p.
|
artikel
|
| 216 |
Varying potency of self/cancer peptides in KIR3DL1 recognition of HLA-A*24:02
|
Barani, S.
|
|
|
85 |
S |
p.
|
artikel
|
| 217 |
Virtual crossmatch (VXM) by the numbers
|
Harville, T.
|
|
|
85 |
S |
p.
|
artikel
|
| 218 |
Virtual desensitization to determine the number and strength of antibody specificities driving High cPRA in a highly sensitized kidney transplant candidate
|
Yin, Y.
|
|
|
85 |
S |
p.
|
artikel
|
| 219 |
39-year-old postpartum G3P2 heart transplant patient with rapid antibody response
|
Clark, A.
|
|
|
85 |
S |
p.
|
artikel
|
Tijdschrift beschrijving